An anti–IL-13 antibody reverses epithelial-mesenchymal transition biomarkers in eosinophilic esophagitis: Phase 2 trial results

Authors:

Abstract
No abstract available
Funding Information
  • Celgene
  • Celgene Corporation

This publication has 34 references indexed in Scilit: